By activating NLRP3, stimulates the production of IL-1β and IL-18 (Zeng et al., 2017; Ge et al., 2018), triggers pyroptosis, and ultimately leads to the development of diabetic cardiomyopathy. This evidence concerns the gene NLRP3 and diabetic cardiomyopathy.